145 related articles for article (PubMed ID: 32981696)
1. Dose-escalated intensity modulated radiation therapy in patients with locally-advanced vulvar cancer - does it increase response rate?
Richman AH; Vargo JA; Ling DC; Sukumvanich P; Berger JL; Boisen MM; Edwards R; Taylor SE; Courtney-Brooks MB; Olawaiye A; Orr BC; Beriwal S
Gynecol Oncol; 2020 Dec; 159(3):657-662. PubMed ID: 32981696
[TBL] [Abstract][Full Text] [Related]
2. Dose escalated neoadjuvant chemoradiotherapy with dose-painting intensity-modulated radiation therapy and improved pathologic complete response in locally advanced esophageal cancer.
Venkat PS; Shridhar R; Naghavi AO; Hoffe SE; Almhanna K; Pimiento JM; Fontaine JP; Abuodeh Y; Meredith KL; Frakes JM
Dis Esophagus; 2017 Jul; 30(7):1-9. PubMed ID: 30052899
[TBL] [Abstract][Full Text] [Related]
3. Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279.
Horowitz NS; Deng W; Peterson I; Mannel RS; Thompson S; Lokich E; Myers T; Hanjani P; O'Malley DM; Chung KY; Miller DS; Ueland FR; Dizon DS; Miller A; Mayadev JS; Leath CA; Monk BJ
J Clin Oncol; 2024 Jun; 42(16):1914-1921. PubMed ID: 38574312
[TBL] [Abstract][Full Text] [Related]
4. Mixed-beam approach in locally advanced nasopharyngeal carcinoma: IMRT followed by proton therapy boost versus IMRT-only. Evaluation of toxicity and efficacy.
Alterio D; D'Ippolito E; Vischioni B; Fossati P; Gandini S; Bonora M; Ronchi S; Vitolo V; Mastella E; Magro G; Franco P; Ricardi U; Krengli M; Ivaldi G; Ferrari A; Fanetti G; Comi S; Tagliabue M; Verri E; Ricotti R; Ciardo D; Jereczek-Fossa BA; Valvo F; Orecchia R
Acta Oncol; 2020 May; 59(5):541-548. PubMed ID: 32090645
[No Abstract] [Full Text] [Related]
5. High-dose intensity-modulated chemoradiotherapy in vulvar squamous cell carcinoma: Outcome and toxicity.
Rishi A; Rollins M; Ahmed KA; Hunt DC; Sarkar P; Fernandez DC; Hoffman MS; Apte SM; Shahzad MMK; Chon HS; Chern JY; Wenham RM; Montejo ME
Gynecol Oncol; 2020 Feb; 156(2):349-356. PubMed ID: 31771865
[TBL] [Abstract][Full Text] [Related]
6. Preoperative intensity modulated radiation therapy and chemotherapy for locally advanced vulvar carcinoma: analysis of pattern of relapse.
Beriwal S; Shukla G; Shinde A; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Richards S; Olawaiye AB; Krivak TC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1269-74. PubMed ID: 23273997
[TBL] [Abstract][Full Text] [Related]
7. A dosimetric evaluation of dose escalation for the radical treatment of locally advanced vulvar cancer by intensity-modulated radiation therapy.
Bloemers MC; Portelance L; Ruo R; Parker W; Souhami L
Med Dosim; 2012; 37(3):310-3. PubMed ID: 22317848
[TBL] [Abstract][Full Text] [Related]
8. Vulvar Recurrences After Intensity-modulated Radiation Therapy for Squamous Cell Carcinoma of the Anus.
Bagshaw HP; Sause WT; Gawlick U; Kim HT; Whisenant J; Cannon GM
Am J Clin Oncol; 2018 May; 41(5):492-496. PubMed ID: 27438690
[TBL] [Abstract][Full Text] [Related]
9. Surgical complications and clinical outcomes after dose-escalated trimodality therapy for non-small cell lung cancer in the era of intensity-modulated radiotherapy.
Liu KX; Sierra-Davidson K; Tyan K; Orlina LT; Marcoux JP; Kann BH; Kozono DE; Mak RH; White A; Singer L
Radiother Oncol; 2021 Dec; 165():44-51. PubMed ID: 34695520
[TBL] [Abstract][Full Text] [Related]
10. Intensity modulated radiation therapy reduces gastrointestinal toxicity in locally advanced pancreas cancer.
Prasad S; Cambridge L; Huguet F; Chou JF; Zhang Z; Wu AJ; O'Reilly EM; Allen PJ; Goodman KA
Pract Radiat Oncol; 2016; 6(2):78-85. PubMed ID: 26577010
[TBL] [Abstract][Full Text] [Related]
11. Intensity-modulated versus 3-dimensional conformal radiotherapy in the definitive treatment of esophageal cancer: comparison of outcomes and acute toxicity.
Haefner MF; Lang K; Verma V; Koerber SA; Uhlmann L; Debus J; Sterzing F
Radiat Oncol; 2017 Aug; 12(1):131. PubMed ID: 28810885
[TBL] [Abstract][Full Text] [Related]
12. Clinical evaluation of intensity-modulated radiotherapy for locally advanced pancreatic cancer.
Goto Y; Nakamura A; Ashida R; Sakanaka K; Itasaka S; Shibuya K; Matsumoto S; Kanai M; Isoda H; Masui T; Kodama Y; Takaori K; Hiraoka M; Mizowaki T
Radiat Oncol; 2018 Jun; 13(1):118. PubMed ID: 29940984
[TBL] [Abstract][Full Text] [Related]
13. Preoperative intensity-modulated radiotherapy and chemotherapy for locally advanced vulvar carcinoma.
Beriwal S; Coon D; Heron DE; Kelley JL; Edwards RP; Sukumvanich P; Zorn KK; Krivak TC
Gynecol Oncol; 2008 May; 109(2):291-5. PubMed ID: 18455637
[TBL] [Abstract][Full Text] [Related]
14. The impact of treatment modality and radiation technique on outcomes and toxicity of patients with locally advanced oropharyngeal cancer.
Al-Mamgani A; van Rooij P; Verduijn GM; Mehilal R; Kerrebijn JD; Levendag PC
Laryngoscope; 2013 Feb; 123(2):386-93. PubMed ID: 23404489
[TBL] [Abstract][Full Text] [Related]
15. Methods, safety, and early clinical outcomes of dose escalation using simultaneous integrated and sequential boosts in patients with locally advanced gynecologic malignancies.
Boyle J; Craciunescu O; Steffey B; Cai J; Chino J
Gynecol Oncol; 2014 Nov; 135(2):239-43. PubMed ID: 25192879
[TBL] [Abstract][Full Text] [Related]
16. Intensity-modulated radiation therapy from 70Gy to 80Gy in prostate cancer: six- year outcomes and predictors of late toxicity.
Jolnerovski M; Salleron J; Beckendorf V; Peiffert D; Baumann AS; Bernier V; Huger S; Marchesi V; Chira C
Radiat Oncol; 2017 Jun; 12(1):99. PubMed ID: 28622770
[TBL] [Abstract][Full Text] [Related]
17. Impact of Intensity-Modulated Radiation Therapy Technique for Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the NRG Oncology RTOG 0617 Randomized Clinical Trial.
Chun SG; Hu C; Choy H; Komaki RU; Timmerman RD; Schild SE; Bogart JA; Dobelbower MC; Bosch W; Galvin JM; Kavadi VS; Narayan S; Iyengar P; Robinson CG; Wynn RB; Raben A; Augspurger ME; MacRae RM; Paulus R; Bradley JD
J Clin Oncol; 2017 Jan; 35(1):56-62. PubMed ID: 28034064
[TBL] [Abstract][Full Text] [Related]
18. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes and late toxicities of 869 patients with nasopharyngeal carcinoma treated with definitive intensity modulated radiation therapy: new insight into the value of total dose of cisplatin and radiation boost.
Ou X; Zhou X; Shi Q; Xing X; Yang Y; Xu T; Shen C; Wang X; He X; Kong L; Ying H; Hu C
Oncotarget; 2015 Nov; 6(35):38381-97. PubMed ID: 26485757
[TBL] [Abstract][Full Text] [Related]
20. Clinical toxicities and dosimetric parameters after whole-pelvis versus prostate-only intensity-modulated radiation therapy for prostate cancer.
Deville C; Both S; Hwang WT; Tochner Z; Vapiwala N
Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):763-72. PubMed ID: 20171807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
